![]() OCTIMET Oncology OCTIMET develops highly selective MET kinase inhibitors with clean safety profiles from Janssen Pharmaceutica. | ![]() NeRRe Therapeutics NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. | ![]() Vita 34 Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries. | ![]() CELLEX CELLEX (also known as BioCom and Biomedical Components) is a company specializing in the development of bioreactors for advanced cell culture and tissue engineering. | ||
Founding Date | Founding Date 2016 | Founding Date 2003 | Founding Date 2012 | Founding Date 1997 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Beerse, BE HQ Gent, BE | Locations Newark, US HQ | Locations Stevenage, GB HQ Hertfordshire, GB | Locations Leipzig, DE HQ Leipzig, DE | Locations Roma, IT HQ |
Employees | Employees 1 | Employees 1292% increase | Employees 9 | Employees 771 | Employees 1 |
Funding | |||||
Latest funding round | Latest funding round $ 13.4m (over 9 years ago) | Latest funding round N/A | Latest funding round $ 30.8m (over 9 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 13.4m | Total funding raised N/A | Total funding raised $ 49.2m | Total funding raised N/A | Total funding raised N/A |

The leading Gene Synthesis and Bioengineering Solutions company.
View company
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
View company
Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries.
View company
CELLEX (also known as BioCom and Biomedical Components) is a company specializing in the development of bioreactors for advanced cell culture and tissue engineering.
View company